A recent survey found that a substantial number of clinicians believe e-cigarettes can help patients reduce or stop smoking, with 37.9% stating they having recommended e-cigarettes to patients who smoke.
New trial data may alleviate some concerns regarding the smoking cessation medications varenline, bupropion and nicotine patches and the risk of neuropsych events.
Studies into the long-term health impact of e-cigarettes - which usually contain nicotine - are limited but of the studies that have been completed, there have been mixed results.
An analysis conducted by UC San Francisco (UCSF) researchers found that rather than aid smoking cessation, e- cigarette users were 28% less likely to quit smoking traditional cigarettes.
Safety Alerts and Recalls
A preliminary analysis of long-term follow-up data (up to 5 years) involving patients with peripheral arterial disease (PAD) treated with paclitaxel-coated products revealed a ‘potentially concerning’ signal of increased long-term mortality when compared with those treated with uncoated devices, according to the Food and Drug Administration (FDA). Among the 3 trials that included 5-year follow-up…
A single dose of psilocybin can alleviate negative moods in patients with life-threatening cancer, a new study has found.